FindTrial
Sign In

Comparing Fatty liver index and Fibroscan parameters for detecting Metabolic dysfunction associated fatty liver disease in Indian adults

Fatty liver index VS FIBROSCAN (Vibration controlled transient elastography ) in diagnosis of Metabolic dysfunction associated fatty liver disease -Balancing accuracy and accessibility in the Indian context - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/099572
Enrollment
57
Registered
2025-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

Praneetha Dandamudi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Willing to give informed consent 2 Clinical suspicion of Metabolic dysfunction associated fatty liver diease based on metabolic risk factors like obesity T2Diabetes dyslipidemia 3 Able to undergo FibroScan and blood investigations

Exclusion criteria

Exclusion criteria: 1 Known history of significant alcohol consumption that is greater than 30g per day for men greater than 20g per day for women to differentiate from alcoholic liver disease. 2 Presence of other known chronic liver diseases like viral hepatitis B or C autoimmune hepatitis primary biliary cholangitis drug-induced liver injury 3 Presence of ascites or other conditions that may interfere with accurate FibroScan measurements. 4 Pregnancy.

Design outcomes

Primary

MeasureTime frame
To evaluate the diagnostic accuracy of the Fatty Liver Index in detecting metabolic dysfunctionnassociated fatty liver disease (MAFLD), using FibroScan as the reference standard, as measured by sensitivity, specificity, positive predictive value, negative predictive value, and the area under the receiver operating characteristic (ROC) curve.Timepoint: 12 months—

Secondary

MeasureTime frame
To determine the optimal cut-off value of the Fatty Liver Index for the diagnosis of MAFLD in the Indian population.Timepoint: 12 months—

Countries

India

Contacts

Public ContactDr Nagender D

Apollo Institute of Medical Sciences and Research

ndevulapally1957@gmail.com9848036415

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026